Loading...
|
Please use this identifier to cite or link to this item:
http://ir.nhri.org.tw/handle/3990099045/13662
|
| Title: | Covid‐19 vaccines in patients with maintenance hemodialysis |
| Authors: | Yen, CC;Lin, SY;Chen, SC;Chiu, YW;Chang, JM;Hwang, SJ |
| Contributors: | Institute of Population Health Sciences |
| Abstract: | The COVID‐19 pandemic has infected more than 180 million people and caused more than 3.95 million deaths worldwide. In addition to personal hygiene, augmented cleaning, social distancing, and isolation, vaccine development and immunization are essential for this highly contagious disease. Patients with maintenance hemodialysis (MHD) have a greater risk of COVID‐19 infection owing to their comorbidities, defective immunity, and repeated crowded in‐center dialysis settings. However, many patients hesitate to get vaccinated because of their misunderstandings. The Efficacy of COVID‐19 vaccination has been intensively discussed in the general population, whereas the data concerning the effectiveness of vaccination in MHD patients are relatively scanty. Nevertheless, those limited publications can provide some valuable information. Overall, lower and more delayed antibody responses following COVID‐19 vaccination were observed in patients with MHD than in healthy controls in the settings of different populations, vaccines and dosage, definitions of the immune response, and antibody detection timepoints. Younger age, previous COVID‐19 infection, and higher serum albumin level were positively associated with antibody formation, whereas older age and receiving immunosuppressive therapy were unfavorable factors. However, it remains uncertain between the elicited antibodies following vaccination and the genuine protection against COVID‐19 infection. Patients with MHD should make their COVID‐19 vaccination a priority in addition to other protective measures. More studies focusing on different vaccines, non‐humoral immune responses, and risk‐benefit analyses are warranted. |
| Date: | 2021-08-12 |
| Relation: | Journal of personalized medicine. 2021 Aug 12;11(8):Article number 789. |
| Link to: | http://dx.doi.org/10.3390/jpm11080789 |
| JIF/Ranking 2023: | http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=NHRI&SrcApp=NHRI_IR&KeyISSN=2075-4426&DestApp=IC2JCR |
| Cited Times(WOS): | https://www.webofscience.com/wos/woscc/full-record/WOS:000689387600001 |
| Cited Times(Scopus): | https://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85113153456 |
| Appears in Collections: | [其他] 期刊論文
|
Files in This Item:
| File |
Description |
Size | Format | |
|---|
| SCP85113153456.pdf | | 269Kb | Adobe PDF | 197 | View/Open |
|
All items in NHRI are protected by copyright, with all rights reserved.
|
